Clinical Trial Update: Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease

View source ↗

Summary

A clinical trial update indicates the REST study evaluating rasagiline's effect on sleep in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Azilect (rasagiline)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Parkinson's Disease | Status: COMPLETED